3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

8-K - Churchill Capital Corp X/Cayman (0002007825) (Filer)

425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

EFFECT - Churchill Capital Corp X/Cayman (0002007825) (Filer)

424B3 - Churchill Capital Corp X/Cayman (0002007825) (Filer)

S-4/A - Churchill Capital Corp X/Cayman (0002007825) (Filer)

S-4/A - Churchill Capital Corp X/Cayman (0002007825) (Filer)

425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

Backed by Wellcome Leap program funding and selected to advance to final-stage demonstrations, Infleqtion moves forward with quantum-enabled biomarker discovery for precision oncology Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, announced that its quantum software team, together with collaborators at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT), has been selected to advance to Phase 3 of the Wellcome Leap Quantum for Bio (Q4Bio) Challenge, a global program focused on demonstrating quantum-enabled solutions for human health. The news comes as Infleqtion prepares to go public through a merger

Combined Company to Trade on NYSE as "INFQ" Churchill Capital Corp X ("Churchill X"), a special purpose acquisition company, today announced Churchill X's intent to transfer the listing of its Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares") and public warrants (the "CCX Warrants") (each, the Common Stock and Warrants following transactions contemplated by the Business Combination, as defined below), from the Nasdaq Stock Market LLC ("Nasdaq") to the New York Stock Exchange (the "NYSE") following, and subject to the completion of, its previously announced business combination with ColdQuanta, Inc. (d/b/a Infleqtion) ("Infleqtion", and such related trans

New research allows for faster computation cycles and more robust error correction, accelerating Infleqtion's path toward industrial-scale neutral-atom quantum computers Infleqtion, a global leader in quantum sensing and quantum computing, announced research results from a collaboration with the University of Wisconsin–Madison that demonstrate a more reliable way to measure individual quantum bits, or qubits, without interrupting ongoing circuits. The work addresses one of the central challenges in quantum computing by enabling faster computation cycles while preserving fragile quantum states. This announcement follows Infleqtion's plans to go public through a merger with Churchill Capita

Kresse is an experienced operating executive with a proven track record driving high growth across both private and public technology companies Infleqtion (the "Company"), a global leader in neutral atom-based quantum computing and quantum sensing, powered by neutral-atom technology, announced the appointment of Dave Kresse as Vice President of Commercial Solutions, effective immediately. Kresse brings more than 30 years of experience building and scaling technology businesses, leading global teams and forging commercial partnerships. He joins Infleqtion after the company announced in September that it plans to go public through a business combination with Churchill Capital Corp X (NASDAQ

Microchip Technology CFO brings decades of public-company finance and governance experience Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, announced the appointment of J. Eric Bjornholt to its Board of Directors effective immediately. Bjornholt brings more than three decades of finance and advisory experience, joining Infleqtion as the Company advances toward its planned public listing. The company announced in September that it plans to go public through a business combination with Churchill Capital Corp X (NASDAQ:CCCX) ("Churchill X"), a special purpose acquisition company. Bjornholt currently serves as Chief Financial Officer

Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced that its joint registration statement on Form S-4 (the "Registration Statement") with Churchill Capital Corp X (NASDAQ:CCCX) ("Churchill X"), filed with Securities and Exchange Commission (the "SEC") in connection with the proposed business combination between Infleqtion and Churchill X, was declared effective by the SEC on January 23, 2026. This represents an important step in the process toward completion of the previously disclosed proposed business combination between Infleqtion and Churchill X. Churchill X has set a meeting date of February 12, 2026 for its extraordi

Sullivan brings extensive strategic expertise in the defence and security sectors, combining decades of front-line military experience with senior leadership appointments across government and industry Infleqtion (the "Company"), a global leader in neutral atom-based quantum technology, announced the appointment of Colin Sullivan MBE as Managing Director of Infleqtion UK effective immediately. In this role, he will spearhead Infleqtion's UK operations, advancing its mission to transform quantum research into deployable capabilities for defence, security, and commercial sectors. Sullivan is joining Infleqtion after the company announced in September that it plans to go public through a bus

Infleqtion, a global leader in neutral-atom–based quantum technology, and Churchill Capital Corp X (NASDAQ:CCCX), a publicly traded special purpose acquisition company, today announced the filing with the U.S. Securities and Exchange Commission of their joint registration statement on Form S-4 (the "Registration Statement") in connection with their proposed business combination. The Registration Statement includes a preliminary proxy statement/prospectus and has not yet been declared effective. The information contained therein is subject to change. The filing follows the confidential submission of a draft registration statement on October 29, 2025 and represents a step in the process towar

Chief Revenue Officer Paul Lipman to participate in conference program at the world's most powerful technology event CES 2026 Infleqtion, a global leader in neutral atom–based quantum technology, will participate in the quantum conference track at CES 2026, taking place January 7-10 in Las Vegas. [As the world's most influential technology event,] CES brings together tens of thousands of innovators, developers, and industry leaders to explore the latest breakthroughs shaping the future of consumer technology. Infleqtion plans to go public through a merger with Churchill Capital Corp X (NASDAQ:CCCX). Paul Lipman, Chief Revenue Officer at Infleqtion, will participate in "Quantum is Now: U

Saffman is recognized for pioneering contributions to quantum simulation and quantum computing with neutral atoms Infleqtion (the "Company"), a global leader in neutral atom-based quantum technology, announced that Chief Scientist for Quantum Information Dr. Mark Saffman was awarded the ninth Biennial John Stewart Bell Prize for Research on Fundamental Issues in Quantum Mechanics and Their Applications. His work underpins Infleqtion's quantum computing roadmap as the company moves toward delivering fault-tolerant quantum systems critical for achieving quantum advantage and unlocking real-world applications for quantum sensing and computing. Infleqtion recently announced plans to go public